Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)LeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Ocular Therapeutix (OCUL) Leases (2019 - 2025)

Ocular Therapeutix has reported Leases over the past 7 years, most recently at $4.6 million for Q4 2025.

  • Quarterly results put Leases at $4.6 million for Q4 2025, down 21.98% from a year ago — trailing twelve months through Dec 2025 was $4.6 million (down 21.98% YoY), and the annual figure for FY2025 was $4.6 million, down 21.98%.
  • Leases for Q4 2025 was $4.6 million at Ocular Therapeutix, down from $5.3 million in the prior quarter.
  • Over the last five years, Leases for OCUL hit a ceiling of $8.0 million in Q4 2022 and a floor of $4.0 million in Q3 2022.
  • Median Leases over the past 5 years was $5.8 million (2024), compared with a mean of $5.8 million.
  • Biggest five-year swings in Leases: skyrocketed 71.53% in 2023 and later decreased 21.98% in 2025.
  • Ocular Therapeutix's Leases stood at $4.9 million in 2021, then skyrocketed by 65.24% to $8.0 million in 2022, then fell by 19.52% to $6.5 million in 2023, then dropped by 8.14% to $5.9 million in 2024, then decreased by 21.98% to $4.6 million in 2025.
  • The last three reported values for Leases were $4.6 million (Q4 2025), $5.3 million (Q3 2025), and $5.9 million (Q2 2025) per Business Quant data.